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Macrophages and dendritic cells (DCs), critical immune 
regulators, demonstrate synergistic cytokine production 
upon co-stimulation with Fc-receptor and Toll-like 
receptor (TLR) ligands. Since cytokine production upon 
TLR-triggering depends on glycolysis, this research 
investigated whether cytokine synergism also requires 
glycolysis. This was analysed in (co)-stimulated human 
macrophages, monocyte-derived DCs (MODCs) and 
retinoic acid DCs (RADCs). We showed that co-
stimulation additionally enhances glycolysis compared to 
TLR-stimulation alone. However, synergism depended on 
glycolysis in RADCs only, whereas macrophages and 
MODCs showed synergistic gene expression, indicating 
translational and transcriptional regulation respectively. 
Elucidating these mechanisms could improve clinical 
manipulation of immune responses.  
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INTRODUCTION 
Antigen presenting cells (APCs) like dendritic cells and 
macrophages play an important modulatory role in both 
innate and adaptive immune reactions. APCs are 
activated upon recognition and uptake of pathogens. 
Subsequently, cytokine production is induced, which 
plays a major role in orchestration of the immune 
response.1 When the adaptive immune response has 
developed, pathogen-specific antibodies are produced that 
opsonize the pathogen.2 Opsonized pathogens can be 
recognized by their molecular patterns and bound by the 
antibodies via pattern-recognizing receptors like Toll-like 
receptors (TLRs) and Fc-receptors (FcRs) respectively on 
APCs. While FcR-triggering on its own induces little 
cytokine production, co-stimulation of both FcR and 
TLRs synergistically enhances cytokine production.1 
For the activation of dendritic cells and M1-type (pro-
inflammatory) macrophages, a switch in cellular 
metabolism from oxidative phosphorylation to glycolysis 
is required.3 In dendritic cells, TLR signaling promotes 
the function of hexokinase 2 (HKII) which catalyses the 
first step in glucose metabolism and is crucial for 
enhancement of glycolytic flux. In general, the glycolytic 
pathway supports de novo fatty acid synthesis in two 
ways. Glycolysis stimulates the pentose phosphate 
pathway (PPP) in which NADPH is generated and 
supplies carbons to the TCA cycle which generates citrate 
that is used in fatty acid synthesis. Fatty acids are then 
used to expand the endoplasmic reticulum and Golgi 
apparatus, stimulating cytokine production at translational 
level.4,5  
Aforementioned findings derived from murine studies 
focused only on the metabolic regulation of TLR induced 
responses. In this research, we sought to determine what 
role metabolism, in particular glycolysis, plays in the 
synergistic effect in cytokine production upon co-
triggering of TLRs and FcRs in human APCs. To this 
end, macrophages and dendritic cells were differentiated 
in vitro from human monocytes, isolated from peripheral 
blood, and stimulated with Pam and/or IgG or IgA. 
Cytokine production and cellular metabolic profiles with 
or without glycolytic inhibitors were analysed to 
determine the role of glycolysis in synergistic cytokine 
production.  
METHODS 
In vitro cell culture and differentiation 
Mononuclear cells were isolated from human peripheral 
blood in a ficoll-amidotrizoaat density gradient. 
Monocytes were separated by MACS® Technology using 
CD14 MicroBeads (Miltenyi Biotec) and purity (>92%) 
was measured by flow cytometry. Monocytes were 
cultured at 37°C, 5% CO2 at a density of 1.75-2*106 cells 
per well in 4 or 5 mL complete medium (RPMI-1640 
containing 10% FCS, 100 U/mL Penicillin, 100 µg/mL 
Streptomycin and 2 mM Glutamate; ThermoFisher). M1 
and M2 macrophages were differentiated in presence of 
GM-CSF (40 ng/mL) or M-CSF (20 ng/ml) respectively. 
For differentiation to monocyte-derived DCs (MODCs), 
GM-CSF (40 ng/mL) and IL-4 (0.86 ng/mL) were added. 
In addition to identical concentrations of GM-CSF and 
IL-4,  retinoic acid (1 µM) was added to obtain retinoic 
acid DCs (RADCs).6 Growth factors were added again at 
identical concentrations during medium refreshment after 
2 or 3 days.  
Cell harvest and stimulation 
Cells were harvested using CellstripperTM (Corning) or 
TrypLE SelectTM (ThermoFisher). For stimulation with 
complexed IgG or IgA, wells were coated by 1 hour 
incubation IgG or IgA (4 and 2 µg/mL respectively) in 
PBS at 37°C. IgA was used to stimulate RADCs, whereas 
M1 and M2 macrophages and MODCs were exposed to 
IgG. Pam3Cys (10 µg/mL) or an equal amount of 
complete medium was added, resulting in four conditions: 
non-stimulated, Pam3Cys-stimulated, IgG/IgA-stimulated 
or Pam3Cys- and IgG/IgA-stimulated cells. Specific 
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 metabolic processes were addressed by treating cells with 
metabolic inhibitors as indicated: oligomycin (1 µM), 2-
DG (1 or 10 mM), UK5099 (50 µM), oxamate (50 mM). 
For cytokine analysis, cells were stimulated in 96-wells 
plates with a density of 25,000 cells in 210 µL. After 24 
hours of stimulation, supernatants were taken and stored 
at -20°C. For metabolic analysis, 10%FCS/RPMI was 
replaced by 10%FCS/XF medium (RPMI medium 
without phosphate or carbonate buffer). 30,000 cells per 
well were plated in XFe96 cell culture microplates 
(Seahorse Bioscience). In order to analyse gene 
expression, 100,000 cells in 400 µL were stimulated for 3 
hours. Cells were harvested, washed with PBS and lysed 
by Buffer RLT supplied with 1% β-mercaptoethanol. 
Cells were stored at -80°C until used for  RNA isolation.  
Metabolic analysis 
To investigate cellular metabolism, the extracellular 
acidification rate (ECAR) and oxygen consumption rate 
(OCR) were analysed with an XF-96 Extracellular Flux 
Analyser (Seahorse Bioscience) as described.7 As lactate 
is produced during glycolytic function, ECAR can be 
used to measure glycolysis. Oxygen consumption is a 
measure of mitochondrial respiration. During the run, 
ECAR and OCR were measured in response to Pam3Cys 
(10 µg/mL), oligomycin, carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP) and a 
combination of antimycin A and rotenone.  
Analysis of produced cytokines 
Interleukin-10 (IL-10) and tumour necrosis factor α 
(TNFα) concentrations in cell supernatants were 
measured by ELISA, using PeliKine IL-10 and TNFα 
ELISA kits (Sanquin) and TNFα ELISA MaxTM Deluxe 
kit (BioLegend). When using Sanquin kits, plates were 
coated overnight with coating antibodies (1:100 in 0.1 M 
Na2CO3 buffer, pH 9.6). To block aspecific binding, 
plates were incubated in PBS/1%BSA for one hour. Then, 
standard dilution series and samples were incubated for 
one hour, followed by one hour incubation with biotin-
conjugated antibodies (1:100). Streptavidine-polyHRP 
(1:10,000) was incubated for 30 minutes. Substrate 
solution was incubated in the dark for approximately 15 
minutes. Reaction was stopped by adding 1.8M H2SO4. 
Plates were read by transmission at 450 nm. When TNFα 
was measured by using BioLegend kits, manufacturer's 
protocol was followed. Except for adding stop solution, 
all steps were preceded by washing with washing buffer 
(0.005% Tween 20 (Sigma-Aldrich) in 1% PBS). 
Gene expression analysis 
For RNA isolation, RNeasy® Plus Mini Kit or RNeasy® 
Mini Kit (Qiagen) was used according to manufacturer's 
protocols, including treatment with DNAse in the latter. 
For cDNA synthesis, a mix was made containing 4 UI 5x 
First-strand buffer, 2 UI 0.1 M DTT, 1 UI RNAseOUT 
(40 U/ul), 1 UI random primers (250 ng/ul), 2 UI dNTPs 
(6.25 mM of dATP, dCTP, dGTP and dTTP each) and 1 
UI mMLV. A control condition without mMLV was 
included. 11 µL of the mix was added to 9 µL RNA. The 
following program was used for cDNA synthesis: 10 min 
25°C, 50 min 37°C, 15 min 70°C. Next, TNFα and IL-10 
expression was measured by RT-PCR. Expression was 
normalized to housekeeping gene β 2-microglobulin. To 2 
µL of 3x diluted cDNA, 8 µL of primer mix was added, 
containing 2 UI H2O, 5 UI 2x SYBR Green (Bio-Rad), 
0.5 UI forward primer (1 µM) and 0.5 UI reverse primer 
(1 µM) (table 1). Expression values were calculated based 
on the ΔΔCt method. 
Table 1 Primer sequences used to determine β 2-
microglubulin, TNFα and IL-10 expression 
Gene Forward and reverse primer 







Monocyte purity (>92%) was measured by using anti-
CD14 (MΦP9). Cell differentiation was ascertained by 
the following markers: anti-CD1A (BL6 or HI149), anti-
CD14 (MΦP9), anti-CD103 (Ber-ACT8), anti-CD163 
(GHI/61) and anti-CD206 (15-2). Fc receptor binding was 
prevented by adding FcR-Block (eBioscience). Aqua-
staining was used to distinguish life cells from dead cells. 
Cells were washed in FACS buffer. For staining, cells 
were incubated at 4°C for 30 minutes in the dark. After 
two washes in FACS buffer, cell staining was measured 
with FACSCanto Flow Cytometer (BD Bioscience).  
Statistical analysis 
Data were analysed with GraphPad Prism version 6 
(GraphPad Software). Multiple t-tests were used 
according to the Holm-Sidak method to determine 
statistical significance (α=5%) of differences between 
TLR- and TLR/FcR-stimulation. One-way ANOVA 
including Tukey’s multiple comparisons was used to 
analyse differences between ECAR- and OCR-values in 
stimulatory conditions.  
RESULTS 
Cell differentiation was achieved 
Cell differentiation was shown to be achieved by 
measuring cell-type specific markers in flow cytometry. 
Moreover, M1 macrophages produced mainly TNFα, 
whereas M2 macrophages showed higher IL-10 levels, 
confirming their pro- and anti-inflammatory character.  
Co-stimulation enhances glycolysis additionally 
Stimulation of all cell types with TLR-ligand Pam3Cys or 
FcR-stimulus Ig showed an enhanced ECAR, indicating 
an increased glycolytic flux (figure 1). Interestingly, co-
stimulation of M1 and M2 macrophages and RADCs 
enhanced glycolysis more than stimulation of FcR alone. 
Moreover, maximal glycolytic capacity of cells was 
increased upon (co)-stimulation. OCR was not 
significantly changed upon stimulation. Since metabolic 
effects were especially clear in M1 macrophages and 
RADCs, further experiments focused on these cells.  
  
Synergistic cytokine production depends on 
glycolysis in RADCs 
Consistent with literature, synergistic cytokine production 
was demonstrated upon co-stimulation of TLRs and FcRs 
in macrophages, MODCs and RADCs.1 Although co-
stimulation showed enhanced glycolysis compared to 
TLR or FcR-stimulation alone, blocking glycolysis with 
2-deoxy-D-glucose (2-DG) did not eliminate synergistic 
TNFα production in macrophages and MODCs (figure 
2A, M1 macrophages shown as example). In contrast, 
synergism upon co-stimulation in RADCs was dependent 
on glycolysis, since glycolytic inhibition abolished 
synergism (figure 2B). Effects on IL-10 production were 
less clear. For RADCs, this was possibly due to low IL-
10 production which hindered accurate measurement. 
 
In addition to inhibition of general glycolysis, metabolic 
processes that glycolysis feeds into were investigated. 
Inhibition of mitochondrial pyruvate shuttling with 
UK5099 or inhibition of ATPase with oligomycin did not 
affect cytokine production. However, blocking of lactate-
dehydrogenase (LDH) with oxamate strongly decreased 
overall cytokine production.  
Synergism at mRNA level in macrophages and 
MODCs but not in RADCs 
At transcriptional level, synergistic gene expression was 
shown upon co-stimulation compared to TLR-stimulation 
in M1 and M2 macrophages and MODCs (figure 3A). 
This effect was independent of glycolysis, since presence 
of 2-DG during stimulation did not alter gene expression. 
In contrast, RADCs did not show this synergism upon co-
stimulation, indicating that cytokine production after co-
stimulation is regulated at translational level (figure 3B). 
 
CONCLUSION 
Co-stimulation of TLRs and FcRs on macrophages and 
dendritic cells induces synergistic cytokine production.1 
This research aimed to investigate whether cellular 
metabolism is involved in this phenomenon. As shown in 
murine cells in previous research5, we demonstrated that 
glycolysis also increases upon Pam3Cys- and Ig-
stimulation in human immune cells. Moreover, this study 
showed that glycolysis seemed to be additionally 
enhanced upon co-stimulation in all cell types. Literature 
already demonstrated that glycolysis supports cytokine 
production at translational level.4,5 Since inhibition of 
glycolysis decreased overall cytokine production, this was 
confirmed in this study. However, synergistic cytokine 
production did not depend on enhanced glycolysis in 
macrophages and MODCs. Moreover, neither inhibition 
of mitochondrial pyruvate shuttling nor inhibition of 
LDH eliminated synergistic cytokine production upon co-
stimulation. This indicates that synergism in these cells is 
not regulated at translational level. In contrast, since 
mRNA levels were synergistically enhanced upon co-
stimulation, regulation takes place at transcriptional level. 
Contrary to M1 and M2 macrophages and MODCs, 
synergistic cytokine production in RADCs was dependent 
on glycolysis. Blocking glycolysis with 2-DG abolished 
synergistic cytokine production upon co-stimulation. No 
synergism was present at mRNA level, pointing towards 
translational regulation. This corresponds with glycolytic 
support of cytokine production by promoting 
endoplasmic reticulum (ER) expansion, hence facilitating 
protein synthesis.4,5 Glycolysis contributes to ER 
expansion by stimulating fatty acid synthesis via citrate 
production in the tricarboxylic acid (TCA) cycle and 
stimulation of the pentose phosphate pathway (PPP) 
which provides NADPH. However, inhibition of pyruvate 
shuttling, thereby blocking the TCA cycle, did not 
eliminate synergistic production. PPP-activation by 
Figure 3 Synergistic TNFα gene expression is present 
upon co-stimulation in M1 macrophages (A), but not in 
RADCs (B). (Relative to Pam3Cys-stimulation; M1: n-4; 
RADC: n=3; error bars depict S.D.) 
 
Figure 1 ECAR is enhanced by TLR- or FcR-stimulation, 
whereas co-stimulation seems to induce an additional increase. 
(Relative to unstimulated condition; M1: n=6; M2, MODC: 
n=4, RADC: n=5; error bars depict S.D.) 
 
 
Figure 2 Inhibition of glycolysis with 2-DG abolishes 
synergistic TNFα production upon co-stimulation in RADCs 
(B) but not in M1 macrophages (A). (Relative to co-
stimulation, normal medium; M1: n=5; RADCs: n=4; error 
bars depict S.D.) 
 glycolysis might be sufficient to stimulate ER expansion. 
Direct inhibition of PPP could clarify the role of this 
pathway. Moreover, other molecules could supply carbon 
atoms for citrate production.  
RA could affect differentiation and cellular function in 
various ways, since both genomic effects by nuclear 
receptor binding and nongenomic effects, such as 
stimulating kinase cascades, have been shown.8 Previous 
studies presented several effects of RA on cytokine 
production that might be involved, e.g. suppression of 
NFκB-dependent gene expression, which includes 
TNFα.9 These processes might be involved in forcing 
cytokine regulation to translational level in RADCs. To 
clarify increased translation, effects of RA on ribosomal 
activity could be studied. For instance, expression of 
ribosomal RNA 18S might be enhanced. 
Collaboration of receptors as presented in this study has 
been shown before. For instance, co-stimulation of 
Dectin-1 and TLR2 leads to synergistic cytokine 
production as well. Dennehy et al demonstrated that Syk, 
which also mediates FcR-signalling, plays an essential 
role in this cooperation in murine macrophages by 
sustaining IκB degradation, thereby elongating nuclear 
localization of NFκB.10 Since synergism in macrophages 
and MODCs was based on enhanced transcription, it 
could be investigated whether this phenomenon plays a 
role in FcR/TLR2 collaboration. Another process that 
could be involved was demonstrated by Vogelpoel et al in 
unpublished data, showing converging stimulation of 
interferon regulatory factor 5 (IRF5). TLR-signaling 
induced IRF5-activation by phosphorylation, whereas 
Syk-activation stimulated nuclear translocation. 
In conclusion, co-stimulation of TLR and FcR enhances 
glycolysis additionally, but this effect is only required for 
synergistic cytokine production in RADCs. Whereas 
macrophages and MODCs showed transcriptional 
regulation, RADCs showed regulation at translational 
level. Further research could focus on differences 
between signalling in cells with transcriptional versus 
translational regulation and the pathways involved in pro-
inflammatory at one hand and anti-inflammatory 
cytokines at the other hand. This knowledge can be used 
to manipulate immune responses in clinical settings.11 For 
instance, we demonstrated that metabolic changes are 
important in the shift of RADCs, a model of intestinal 
tolerogenic DCs6, towards a pro-inflammatory profile, 
producing more TNFα. Targeting metabolism could be a 
therapeutic strategy to either stimulate or inhibit the pro-
inflammatory response: an anti-bacterial immune 
response should be increased, whereas dampening of 
inflammation is needed in inflammatory bowel disease 
for example. 
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